The abrupt postponement of the U.S. Preventive Services Task Force meeting fuels fears of political interference and upheaval in evidence-based medical guidance.
In one of the studies, physicians aided by the DermaSensor device correctly referred 91.4% of cancers, compared with 82.0% without the device — a 50% reduction in missed cancer referrals.